Rallybio declares $13.56/share special cash distribution (~$82.7M) tied to Avenzo merger

Rallybio Corp

Special cash distribution estimated at $82.7M aggregate, or $13.56 per share, based on 6,378,168 shares and equivalents outstanding as of October 21, 2026.
Record date November 5, 2026; funds deposited with transfer agent that day and scheduled for distribution November 13, 2026; Nasdaq ex-dividend date November 6, 2026.
Due bill period expected November 4-6, 2026: buyers in that window receive the distribution; holders must hold through November 6, 2026 to be entitled.
Payment conditioned on the required stockholder vote at the annual meeting set for 10:00 a.m. ET on November 4, 2026; merger closing expected on or about November 6, 2026.
Board also fixed the November 5, 2026 record date for the previously announced contingent value rights distribution; actual cash amount may be higher or lower than the $82.7M estimate.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.